Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cell and Gene Therapy
Sort By
Newest First
1 / 20
1 / 20
dbDNA
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Jill Makin
Touchlight
PAO-08-24-CL-01
Aug 19, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03
Jul 22, 2024
Cell and Gene Therapy
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Erin Schaller; Aidan Jones
PPD, part of Thermo Fisher Scientific
PAO-06-24-CL-11
Jul 09, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01
Jul 02, 2024
Cell Therapy
Facilitating Organoid Production for Biopharmaceutical Applications
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-12
Jul 02, 2024
Synthetic DNA
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Tom Merritt, Ph.D.
Touchlight
PAO-07-24-CL-01
Jul 02, 2024
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02
Jun 11, 2024
Cell Therapy
Intelligent Cell Processing Enables Consistent, Reproducible, and Scalable GMP-Compliant Processes
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-07
May 30, 2024
Exosomes
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-24-NI-01
May 09, 2024
Cell and Gene Therapy Regulatory
Navigating Regulatory Complexity for Cell and Gene Therapies
Natasha Rivas
PAO-04-24-CL-03
Apr 12, 2024
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Genezen
PR-M03-24-01-5831
Mar 06, 2024
Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen
PR-M02-05-02
Feb 21, 2024
Cell Therapy Manufacturing
Rethinking Cell Engineering for Cell Therapy Manufacturing
Todd Sulchek, Ph.D
CellFE
PAO-11-23-CL-03
Dec 13, 2023
Stem Cell Therapy
Designing A Recipe for Stem Cell Therapy Success
Ben Josey, Ph.D.; Robert Padilla
Corning Life Sciences
PTV-12-23-CL-01
Dec 12, 2023
Cell and Gene Therapy
Scaling Cell and Gene Therapy Processes from R&D to Production
Shawn Bates; Antonio Fernandez-Perez, Ph.D.
Corning Life Sciences
PAO-12-23-CL-03
Dec 12, 2023
Viral Vectors
Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies
Jimmy Vanhove
Viralgen Vector Core
PAO-11-23-CL-02
Nov 28, 2023
Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33
Nov 01, 2023
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
PR-M10-23-05
Oct 19, 2023
Cell and Gene Therapy Distribution
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies
PR-M10-23-03-44
Oct 13, 2023